SARS-CoV-2 diagnosis in saliva samples: Usefulness and limitations

ElsevierVolume 109, Issue 3, July 2024, 116320Diagnostic Microbiology and Infectious DiseaseAuthor links open overlay panel, , , , , , , , , , Highlights•

SARS-CoV-2 Diagnostic test not requiring RNA extraction

Processing and cost-efficient test

Saliva collecting system allowed for RNA quality to be maintained up to one year

Abstract

Saliva samples are important for diagnosis, because they are noninvasive and easy to acquire. The objective of this cross-sectional study was to investigate the value saliva samples have in detecting SARS-CoV-2 in comparison to nasal swabs and a new system named CovidCheck. A standard methodology identified the virus in 185 nasopharyngeal swabs and saliva samples revealing a sensitivity, specificity and positive and negative predictive values of 82,100,100 and 94.67%, respectively for saliva samples. Viral presence in saliva samples with the standard methodology in comparison to the CovidCheck system was evaluated in 67 samples with sensitivity, specificity and positive and negative predictive values of 68, 81, 68 and 81%, respectively. In conclusion, our results highlight the usefulness saliva samples have in detecting respiratory viral infections. However, presence of viral inhibitors and viral load in saliva, and the patient's clinical status should be considered as they might affect amplifying systems results.

Keywords

COVID-19

qRT-PCR

Nasopharyngeal swabs

Saliva

© 2024 The Author(s). Published by Elsevier Inc.

留言 (0)

沒有登入
gif